CAC 40
8 088,24 +71,59 (+0,89 %) Euro Stoxx 50
5 006,85 +67,84 (+1,37 %) Dow Jones
38 239,66 +153,86 (+0,40 %) EUR/USD
1,0699 -0,0034 (-0,32 %) Gold future
2 349,60 +7,10 (+0,30 %) Bitcoin EUR
58 782,54 -1 192,22 (-1,99 %)
Carl Zeiss Meditec AG (AFX.DE)
Carl Zeiss Meditec AG
Goschwitzer Strasse 51-52
Jena 07745
Germany
49 3641 220 115
https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir
Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 4 823
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Dr. Markus Weber | CEO & Chairman of Management Board | 905,4k | S.O. | S.O. |
| Mr. Justus Felix Wehmer | CFO & Member of the Management Board | 609,4k | S.O. | 1965 |
| Dr. Christian Munster | Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board | S.O. | S.O. | 1971 |
| Stefanie Spanagel | Chief Operating Officer | S.O. | S.O. | S.O. |
| Mr. Sebastian Frericks | Director of Investor Relations | S.O. | S.O. | S.O. |
| Eva-Maria Heine | Chief Human Resources Officer | S.O. | S.O. | S.O. |
| Mr. Steven C. Schallhorn M.D. | Chief Medical Officer for Global Ophthalmic Devices | S.O. | S.O. | S.O. |
| Mr. Andrew Chang | Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. | S.O. | S.O. | S.O. |
| Dr. Euan S. Thomson Ph.D. | President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit | S.O. | S.O. | 1963 |
| Mr. Magnus Reibenspiess | Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology | S.O. | S.O. | S.O. |
Description
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Carl Zeiss Meditec AG en date du 1 avril 2024 est 8. Les scores principaux sont Audit : 4; Société : 7; Droits des actionnaires : 6; Compensation : 8.
